Ousia Pharma is a biotech spin-out from the University of Copenhagen developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases. The company uses a proprietary targeting approach in which peptides are used to deliver modulators of synaptic plasticity to drive a potent and sustained weight loss without compromising safety. A main objective of Ousia Pharma is to advance the development of the lead weight loss drug candidate (OP-56) within general obesity.
Company Details
- Employees
- 8
- Address
- Copenhagen, Dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ousiapharma.com
- Keywords
- IT Consulting.
- HQ
- Copenhagen
Ousia Pharma Questions
Ousia Pharma's website is http://www.ousiapharma.com
Ousia Pharma's LinkedIn profile is https://dk.linkedin.com/company/ousiapharma
Ousia Pharma has
8 employees.
View email and phone details for 8
employees at Ousia Pharma.
Ousia Pharma's industry is
Biotechnology Research
Ousia Pharma's top competitors are
Gubra,
Avilex Pharma Aps,
Omega Funds,
Boost Pharma,
Zerion Pharma,
Acesion Pharma,
Solid Therapeutics,
Oasicare,
Alea Quantum Technologies,
Bioinnovation Institute.
Ousia Pharma's categories are Biotechnology Research
